- Home
- GROY vs CDNA Comparison
GROY vs CDNA Comparison
Compare GROY & CDNA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- GROY
- CDNA
- Stock Information
- Founded
- GROY 2020
- CDNA 1998
- Country
- GROY Canada
- CDNA United States
- Employees
- GROY N/A
- CDNA N/A
- Industry
- GROY
- CDNA Medical Specialities
- Sector
- GROY
- CDNA Health Care
- Exchange
- GROY Nasdaq
- CDNA Nasdaq
- Market Cap
- GROY 618.0M
- CDNA 712.2M
- IPO Year
- GROY 2021
- CDNA 2014
- Fundamental
- Price
- GROY $3.60
- CDNA $14.67
- Analyst Decision
- GROY Strong Buy
- CDNA Buy
- Analyst Count
- GROY 5
- CDNA 8
- Target Price
- GROY $5.00
- CDNA $26.86
- AVG Volume (30 Days)
- GROY 3.9M
- CDNA 1.0M
- Earning Date
- GROY 11-05-2025
- CDNA 11-04-2025
- Dividend Yield
- GROY N/A
- CDNA N/A
- EPS Growth
- GROY N/A
- CDNA N/A
- EPS
- GROY N/A
- CDNA 1.00
- Revenue
- GROY $12,376,000.00
- CDNA $340,826,000.00
- Revenue This Year
- GROY $79.54
- CDNA $12.73
- Revenue Next Year
- GROY $59.80
- CDNA $11.90
- P/E Ratio
- GROY N/A
- CDNA $14.71
- Revenue Growth
- GROY 90.37
- CDNA 14.72
- 52 Week Low
- GROY $1.16
- CDNA $10.96
- 52 Week High
- GROY $4.15
- CDNA $26.37
- Technical
- Relative Strength Index (RSI)
- GROY 47.82
- CDNA 50.53
- Support Level
- GROY $3.43
- CDNA $14.03
- Resistance Level
- GROY $3.73
- CDNA $15.13
- Average True Range (ATR)
- GROY 0.23
- CDNA 0.60
- MACD
- GROY -0.03
- CDNA -0.05
- Stochastic Oscillator
- GROY 32.89
- CDNA 44.31
About GROY Gold Royalty Corp.
Gold Royalty Corp is a precious metals-focused royalty and mineral streaming company. The company offers creative financing solutions to the metals and mining industry. The company's mission is to acquire royalties, streams and similar interests at varying stages of the mine life cycle to build a balanced portfolio offering near, medium and longer-term attractive returns for investors. It has its business as a single operating segment, being the investment in royalty and mineral stream interests. The company derives maximum revenue from Canada.
About CDNA CareDx Inc.
CareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically the company generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.